Skip to main content
logo
Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
39.75
-0.07 (-0.16%)
May 29, 2026, 12:48 PM EDT - Market open

Centessa Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '20
Revenue
-15-6.85--
Gross Profit
-15-6.85--
Selling, General & Admin
58.0250.4750.8153.7355.21.14
Research & Development
198.67172.22150.24124.41155.089.3
Other Operating Expenses
----1.98-
Total Operating Expenses
256.69222.69201.06178.14212.2610.44
Operating Income
-256.69-207.69-201.06-171.28-212.26-10.44
Interest Income
17.7820.5314.0210.480.24-
Interest Expense
-11.31-11.46-10.09-9.91-7.28-0.31
Other Non-Operating Income (Expense)
0.862.91-35.78-5.432.340.09
Total Non-Operating Income (Expense)
7.3211.98-31.86-4.86-4.69-0.22
Pretax Income
-249.37-195.71-232.91-176.14-216.95-10.66
Provision for Income Taxes
1.271.822.84-25.06-0.75-
Net Income
-250.64-197.53-235.76-151.09-216.21-10.66
Net Income to Common
-250.64-197.53-235.76-151.09-216.21-10.66
Shares Outstanding (Basic)
14113611496934
Shares Outstanding (Diluted)
14113611496934
Shares Change (YoY)
14.78%18.56%19.02%2.97%2283.79%-
EPS (Basic)
-1.79-1.46-2.06-1.57-2.31-0.80
EPS (Diluted)
-1.79-1.46-2.06-1.57-2.31-0.80
Shares Outstanding
154.73149.23132.6396.1894.847.5
Free Cash Flow
-209.1-194.19-142.09-160.51-201.68-10.63
Free Cash Flow Per Share
-1.48-1.43-1.24-1.67-2.16-2.71
Gross Margin
-100.00%-100.00%--
Operating Margin
--1384.61%--2499.39%--
Profit Margin
--1316.88%--2204.65%--
FCF Margin
--1294.59%--2342.20%--
EBITDA
-255.75-206.77-200.11-170.47-212.13-10.44
EBITDA Margin
--1378.47%--2487.57%--
EBIT
-256.69-207.69-201.06-171.28-212.26-10.44
EBIT Margin
--1384.61%--2499.39%--
Effective Tax Rate
-0.51%-0.93%-1.22%14.22%0.34%0.00%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q